Literature DB >> 18091179

The effect of paclitaxel on conjunctival wound healing: a pilot study.

Ozlem Gurbuz Koz1, Serife Ozhuy, Gaye Guler Tezel, Nazmiye Karaman, Nursen Unlu, Alper Yarangumeli, Gulcan Kural.   

Abstract

PURPOSE: To compare the effects of mitomycin C (MMC) and paclitaxel entrapped within Carbopol 980 hydrogel (CH) on conjunctival wound healing.
METHODS: Twenty rabbits were randomized into 2 groups. In group 1, limbal-based conjunctival flaps were created in both eyes. In this stage, eyes were randomized for 4 different processes. In process 1, a dry cellulose sponge soaked with 0.2 mg/mL of MMC was applied to the scleral surface. A cellulose sponge soaked with balanced saline solution was applied in the same manner in process 2. In process 3, paclitaxel 1 mg/mL entrapped within CH was placed between the conjunctiva and sclera. In process 4, CH without paclitaxel was applied in the same manner. The conjunctiva was then sutured. All procedures were applied in the same manner in both eyes of animals in group 2. Eyes from group 1 were sampled at the seventh day, and the sampling was also carried out in group 2 on day 14. The inflammatory response and fibrosis were evaluated with light microscopy.
RESULTS: Among 4 different processes, lower cell counts and fibrosis scores were found in eyes treated with MMC and paclitaxel compared with balanced saline solution and CH groups (P<0.05). There was no difference between eyes treated with MMC and paclitaxel in terms of these histopathologic parameters (P>0.05).
CONCLUSIONS: Paclitaxel was shown to provide MMC-like antifibrotic effects during conjunctival wound healing, particularly when delivered with CH and might be a promising alternative as an adjunctive antimetabolite in glaucoma filtration surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18091179     DOI: 10.1097/IJG.0b013e31815c89b9

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  8 in total

1.  Paclitaxel-Releasing Thin Biodegradable Film for Prevention of Bleb Avascularity Without Compromising Filtration in Rabbits.

Authors:  Tetsuhiko Okuda; Tomomi Higashide; Mayumi Sakurai; Yukako Fukuhira; Hiroaki Kaneko; Masatsugu Shimomura; Kazuhisa Sugiyama
Journal:  Transl Vis Sci Technol       Date:  2015-06-11       Impact factor: 3.283

2.  [Pathophysiology of fibrotic encapsulation of episcleral glaucoma drainage implants: modification for improvement of clinical results].

Authors:  L Choritz; M Wegner; R Förch; U Jonas; H Thieme
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

3.  Taxol and taurine protect the renal tissue of rats after unilateral ureteral obstruction: a stereological survey.

Authors:  Saied Karbalay-Doust; Ali Noorafshan; Seyed-Mohammad Pourshahid
Journal:  Korean J Urol       Date:  2012-05-18

4.  Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery.

Authors:  Lei Xi; Tao Wang; Feng Zhao; Qiongjuan Zheng; Xiaoning Li; Jing Luo; Ji Liu; Daping Quan; Jian Ge
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

5.  Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices.

Authors:  Lars Choritz; Jochen Grub; Maria Wegner; Norbert Pfeiffer; Hagen Thieme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-07       Impact factor: 3.117

6.  Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.

Authors:  Nikolai Gross; Mahdy Ranjbar; Charlotte Evers; Jing Hua; Gottfried Martin; Brita Schulze; Uwe Michaelis; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Mol Vis       Date:  2013-01-10       Impact factor: 2.367

Review 7.  Wound Healing Modulation in Glaucoma Filtration Surgery- Conventional Practices and New Perspectives: Antivascular Endothelial Growth Factor and Novel Agents (Part II).

Authors:  Jennifer C Fan Gaskin; Dan Q Nguyen; Ghee Soon Ang; Jeremy O'Connor; Jonathan G Crowston
Journal:  J Curr Glaucoma Pract       Date:  2014-06-12

8.  Limbal stem cell deficiency secondary to systemic paclitaxel (Taxol) for breast cancer: a case report.

Authors:  Amardeep Sekhon; Jeff Y F Wang; Johnson C H Tan; Simon P Holland; Sonia N Yeung
Journal:  BMC Ophthalmol       Date:  2020-10-07       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.